Clinical, Virologic, and Immunologic Response to Efavirenz- or Protease Inhibitor-Based Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive Patients with Advanced HIV Infection (EfaVIP 2 Study)

1. Pulido, F.
2. Arribas, J.R.
3. Miró, J.M.
4. Costa, M.A.
5. González, J.
6. Rubio, R.
7. Peña, J.M.
8. Torralba, M.
9. Lonca, M.
10. Lorenzo, A.
11. Cepeda, C.
12. Vázquez, J.J.
13. Gatell, J.M.